There’s a disease story unfolding right now in Australia that hasn’t made the front page in most capital cities. That gap between significance and coverage is its own kind of commentary on whose health gets sustained attention.

On 22 May 2026, Australia’s Chief Medical Officer declared the current diphtheria outbreak a Communicable Disease Incident of National Significance — the same formal designation used for COVID-19 in 2020. The Australian Centre for Disease Control’s epidemiological summary confirmed 221 cases across four jurisdictions as of the declaration date. That figure is 29.8 times the average case count for the same period in 2022 to 2025. Not 29.8 percent more. Twenty-nine-point-eight times.

If you have family in the Northern Territory or Western Australia, or if your own diphtheria-tetanus booster status hasn’t crossed your mind in a decade, this is worth a slow read.

The both-and

The outbreak is real, serious, and geographically concentrated — and it tells two stories simultaneously, both of which are true.

Vaccines are working, partly. According to the ACDC, national diphtheria-tetanus-pertussis vaccination coverage at age five is 93.4%, with Aboriginal and Torres Strait Islander children slightly higher at 94.7%. That coverage is almost certainly moderating the severity picture. The majority of cases — 67.9% — are cutaneous diphtheria, which presents as slow-healing skin ulcers caused by Corynebacterium diphtheriae. Cutaneous diphtheria carries significant morbidity and is transmissible, but it is a different clinical entity from respiratory diphtheria. Respiratory diphtheria — the form that produces the pseudomembrane, airway obstruction, and systemic toxin spread to the myocardium, peripheral nerves, and kidneys — accounts for 31.7% of cases. The vaccination coverage on the books is almost certainly suppressing the most severe end of the disease spectrum.

Coverage is necessary, but not sufficient here. The Conversation’s analysis of the outbreak names several structural factors the case count alone doesn’t explain. Diphtheria toxoid immunisation confers stronger protection against respiratory diphtheria than against cutaneous disease. In high-contact, resource-limited settings, transmission outpaces the protection conferred by population averages. And adult booster coverage — adults have no school-based catch mechanism — is inconsistently documented across the affected communities. More than 94% of confirmed cases are among Aboriginal and/or Torres Strait Islander people, and 96.8% are in outer regional, remote, or very remote areas. This is not a story about vaccine refusal. It is a story about the reach of the system — and where that reach currently stops.

The ACDC epidemiological summary also flags something worth watching nationally: fully immunised rates in the five-year-old cohort have been gradually declining since peaking in 2020. Small coverage declines translate into larger vulnerability gaps in high-transmission settings. The two facts sit together uncomfortably — Australia has among the highest childhood vaccination rates in the world, and that has not been sufficient to prevent the largest diphtheria outbreak on record.

2 cents

For most Australians in metropolitan settings, the direct personal risk of contracting diphtheria right now is low. The transmission dynamics of this outbreak — concentrated geographic spread, skin-contact and respiratory-droplet routes in high-contact settings — reflect specific structural conditions, not general urban community spread.

Two things are worth considering regardless of where you live. First, check when you last had a diphtheria-tetanus (dT) or dTpa booster. Adults are recommended a booster at least once in adulthood, ideally decennially — many people are genuinely unsure whether they’ve had one. That conversation takes thirty seconds at your next GP appointment and is worth having. Second, if you have family or connections in the affected regions — particularly the NT and WA — the ACDC’s clinical guidance is clear: any non-healing skin wound or ulcer in an outbreak-affected area warrants medical assessment. Cutaneous diphtheria is not a wound that simply fails to heal on its own timeline; early assessment matters.

The Australian College of Nursing has produced clinical resources on recognising both cutaneous and respiratory presentations — worth reading if you are working in or near affected communities.

This is general information in nature. Your own vaccination history, risk profile, and any concerning skin presentations are the clinical conversation to have with your GP — the specific assessment isn’t something an article can substitute.

Verdict

Verdict: yes — worth knowing about.

Australia’s largest diphtheria outbreak on record is active and concentrated in Aboriginal and Torres Strait Islander communities in remote NT and WA, and it has received far less public attention than its designation warrants. The public health response is underway — with federal funding supporting the NT Government and the Aboriginal Community Controlled Health Sector. For most people reading this, the personal action is modest: know your booster status. For clinicians seeing patients from affected regions, early recognition of cutaneous presentations is the immediate clinical priority. This is the kind of outbreak the system is designed to contain — and also the kind that exposes where the design still has gaps.

Australia's diphtheria outbreak declared nationally significant

The both-and

2 cents

Verdict

Sources cited